NASDAQ
Knight Therapeutics Inc. (KHTRF) has a revenue compound annual growth rate of 17.65% over 5 years and 83.53% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.